ZOLL signs definitive agreement to purchase Cardiac Science

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

Current Location:
> This Story

Forward Printable StoryPrint Comment




Cardiology Homepage

Abbott receives U.S. approval of next-generation MitraClip, bringing new enhancements to Abbott's leading MitraClip platform

Telehealth Technology to reduce hospital readmissions and improve outcomes for cardiac disease patients

FDA approves Bayer's Gadavist (gadobutrol) injection as first contrast agent for use in cardiac MR in adult CAD patients

New technology improves atrial fibrillation detection after stroke

New study of ultrasound enhancing agents in echocardiography reaffirms safety profile of LUMASON

Johns Hopkins Medicine researchers identify health conditions likely to be misdiagnosed

Team approach to cardiac care increases chance of surviving heart attack complications

Philips supports CNIC to shape the future of cardiac care

Cardiac arrest among hospitalized patients may be underestimated

RAPID receives registration approval in Japan

ZOLL signs definitive agreement to purchase Cardiac Science

Press releases may be edited for formatting or style
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has signed a definitive agreement to purchase Cardiac Science Corporation (CSC), a leading provider of automated external defibrillators (AEDs), related services, and accessories. CSC is a portfolio company of Aurora Resurgence, a Los Angeles-based private equity investment firm.

“We are excited about the alignment of our two companies and our combined ability to put life-saving technology in the hands of more lay rescuers and first responders answering medical emergencies,” said Elijah A. White, President of ZOLL Resuscitation. “ZOLL and Cardiac Science have been delivering AED solutions for the better part of two decades. As we look to the future together, our combined organization will provide more choices to current and future customers. This includes continuing to actively promote, market, and supply the Powerheart® line of AEDs and Rescue Ready® services in addition to our ZOLL AEDs and PlusTrac™ program management. Moving forward, ZOLL plans to continue ongoing development and to introduce new products for both Powerheart and ZOLL brands.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

“Joining ZOLL is the right opportunity for our business, our people, and our customers,” said Dev Kurdikar, President and CEO of Cardiac Science. “We are enthusiastic that our combined portfolios will be able to address a greater range of needs for our customers and look forward to accelerated innovation to meet persistent needs in the community for these vital emergency services. By expanding the reach of our current and future line of Powerheart AEDs, we will be able to further fulfill our mission of saving lives.”

White highlighted that one of the benefits of joining forces is the expansion of ZOLL’s lifesaving AED management programs to a larger number of AEDs. ZOLL’s AED Link™ connects first responders with the closest available AED. Today, publicly available AEDs are sometimes not retrieved and used because bystanders cannot see them and 9-1-1 dispatchers are unaware they are nearby. ZOLL’s technology enables dispatchers to communicate the locations of registered AEDs to callers reporting potential sudden cardiac arrest incidents. With the addition of Cardiac Science to the AED Link program more 9-1-1 agencies will be able to help put AEDs in the hands of laypersons and first responders to support life-saving action.
  Pages: 1 - 2 >>

Cardiology Homepage

You Must Be Logged In To Post A Comment